← Eichor
Study identifier: NCT05353946 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Coronary Rotational Atherectomy Elective vs. Bailout in Severely Calcified Lesions and Chronic Renal Failure

Condition: Coronary Artery Disease · Chronic Renal Failure  ·  Sponsor: Guillermo Galeote; MD, PhD

PhaseNA
Planned participants124
Who can joinAll sexes, 18 Years to 100 Years
Healthy volunteersNo

About this study

The current role of the rotational atherectomy is for non-dilatable coronary lesions and for severely calcified lesions that may interfere with optimal stent expansion. Severely calcified coronary lesions are associated with worse outcomes. In this regard, chronic kidney disease is associated with severely calcified coronary arteries. Some evidence suggests that elective rotational atherectomy used by experienced operators can be safe and effective, minimizing time and complications for patients with heavily calcified lesions. However, there is no direct randomized comparison between rotational atherectomy and angioplasty alone in the setting of chronic renal failure and with intravascular ultrasound assessment for detecting severely calcified coronary arteries.

This description comes directly from the study's public registry record.

Talk to the study team

Guillermo Galeote, PhD, MD  ·  +34609024315  ·  ggaleote1@gmail.com

Artemio García-Escobar, MD  ·  +34608936547  ·  dr_garciaescobar@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

La Paz University HospitalMadrid, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05353946